Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00984750 |
|
Recruitment Status :
Completed
First Posted : September 25, 2009
Last Update Posted : February 25, 2013
|
Sponsor:
Mario Negri Institute for Pharmacological Research
Collaborator:
Leadiant Biosciences, Inc.
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | May 2012 |
| Actual Study Completion Date : | December 2012 |